TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.

Ritu Chaudhary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.